Search Press releases

25 Apr 2024

金禾娱乐城’s General Meeting of Shareholders 2024

Read More
25 Apr 2024

金禾娱乐城 off to a Good Start into 2024 – Progressing on its Growth Path for a Decade Plus

Read More
23 Apr 2024

Transparency notification FMR LLC

Read More
22 Apr 2024

金禾娱乐城 receives European Commission approval for BIMZELX[?]▼(bimekizumab) as the first IL-17A and IL-17F biologic for moderate to severe hidradenitis suppurativa

Read More
19 Apr 2024

Acquisition of own shares

Read More
17 Apr 2024

FINTEPLA[?]▼ (fenfluramine) oral solution approved in Japan for adjunctive treatment of seizures associated with Lennox-Gastaut syndrome (LGS)

Read More

Stay up-to-date on the latest news and information from 金禾娱乐城